Zkusit zdarma
MoonLake Immunotherapeutics

MoonLake Immunotherapeutics

MLTX
Cena:
$ 18.19
-0.28 (-1.52%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
FDA Aligns With MoonLake On Lead Drug Submission Plans, Stock Soars

FDA Aligns With MoonLake On Lead Drug Submission Plans, Stock Soars

11:44 11-05-2026

MoonLake Immunotherapeutics (NASDAQ:MLTX) shares are up during Monday's trading session, trading hig...

MoonLake Clears A Key Regulatory Hurdle, And Shares Rocket

MoonLake Clears A Key Regulatory Hurdle, And Shares Rocket

11:08 11-05-2026

Shares of MoonLake Immunotherapeutics bounded higher Monday after the biotech said it met with the F...

MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results

MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results

9:00 10-05-2026

ZUG, Switzerland, May 10, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake” or the...

The CEO of MoonLake Immunotherapeutics Dumped Shares Worth $2.8 Million. Should Investors Avoid the Stock?

The CEO of MoonLake Immunotherapeutics Dumped Shares Worth $2.8 Million. Should Investors Avoid the Stock?

10:17 18-04-2026

CEO Jorge Santos da Silva sold 150,000 shares for a transaction value of approximately ~$2.75 millio...

Da Silva Jorge Santos Sells 98,127 Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock

Da Silva Jorge Santos Sells 98,127 Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock

4:05 16-04-2026

MoonLake Immunotherapeutics (NASDAQ: MLTX - Get Free Report) CEO Da Silva Jorge Santos sold 98,127 s...

MoonLake Immunotherapeutics (NASDAQ:MLTX) Trading Down 6% – Should You Sell?

MoonLake Immunotherapeutics (NASDAQ:MLTX) Trading Down 6% – Should You Sell?

4:11 12-04-2026

MoonLake Immunotherapeutics (NASDAQ: MLTX - Get Free Report)'s share price traded down 6% during mid...

Biotech Fund BVF Trims MoonLake Stake, Sells $63M in Shares

Biotech Fund BVF Trims MoonLake Stake, Sells $63M in Shares

14:07 07-04-2026

BVF sold 3,750,000 shares for a transaction value of approximately $62.96 million on April 2, 2026. ...

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting

15:00 28-03-2026

ZUG, Switzerland, March 28, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (MoonLake or the Com...

MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Gap Up After Analyst Upgrade

MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Gap Up After Analyst Upgrade

1:32 20-03-2026

MoonLake Immunotherapeutics (NASDAQ: MLTX - Get Free Report) gapped up prior to trading on Thursday ...

This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know?

This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know?

19:36 16-03-2026

Cormorant Asset Management increased its MoonLake Immunotherapeutics position by 2,361,260 shares in...

Avoro Capital Advisors LLC Cuts Stock Position in MoonLake Immunotherapeutics $MLTX

Avoro Capital Advisors LLC Cuts Stock Position in MoonLake Immunotherapeutics $MLTX

3:07 14-03-2026

Avoro Capital Advisors LLC lessened its holdings in shares of MoonLake Immunotherapeutics (NASDAQ: M...

MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Recommendation of “Hold” from Analysts

MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Recommendation of “Hold” from Analysts

2:50 13-03-2026

MoonLake Immunotherapeutics (NASDAQ: MLTX - Get Free Report) has been assigned a consensus recommend...

MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal

MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal

13:50 24-02-2026

MoonLake Immunotherapeutics is downgraded from Strong Buy to Buy following a mixed phase 3 outcome f...

MoonLake Immunotherapeutics Investor Day: HS BLA on Track, axSpA Phase 2 Data Highlights Imaging Wins

MoonLake Immunotherapeutics Investor Day: HS BLA on Track, axSpA Phase 2 Data Highlights Imaging Wins

1:16 24-02-2026

MoonLake Immunotherapeutics (NASDAQ: MLTX) used its Investor Day presentation to outline updates acr...

MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript

MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript

15:24 23-02-2026

MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript...

MoonLake Immunotherapeutics Data Shows Phase 2 Success For Chronic Back Pain

MoonLake Immunotherapeutics Data Shows Phase 2 Success For Chronic Back Pain

9:10 23-02-2026

Axial Spondyloarthritis is a chronic, immune-mediated inflammatory disease mainly affecting the spin...

MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results

MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results

11:00 22-02-2026

In the Phase 2 S-OLARIS clinical trial in axial spondyloarthritis (axSpA), sonelokimab (SLK) demonst...

Principal Financial Group Inc. Invests $509,000 in MoonLake Immunotherapeutics $MLTX

Principal Financial Group Inc. Invests $509,000 in MoonLake Immunotherapeutics $MLTX

3:21 20-02-2026

Principal Financial Group Inc. purchased a new stake in MoonLake Immunotherapeutics (NASDAQ: MLTX) i...

BioTech Breakout: MoonLake Up 30% On FDA Wins

BioTech Breakout: MoonLake Up 30% On FDA Wins

15:48 03-02-2026

In a stock market currently obsessed with interest rate cuts and the artificial intelligence (AI) bo...

MoonLake Immunotherapeutics (NASDAQ:MLTX) versus Nuvation Bio (NYSE:NUVB) Critical Review

MoonLake Immunotherapeutics (NASDAQ:MLTX) versus Nuvation Bio (NYSE:NUVB) Critical Review

3:30 18-01-2026

Nuvation Bio (NYSE: NUVB - Get Free Report) and MoonLake Immunotherapeutics (NASDAQ: MLTX - Get Free...

close

IMAGENEBIO APPOINTS IMMUNOLOGY DRUG DEVELOPMENT VETERAN DR. BEN PORTER-BROWN AS CHIEF MEDICAL OFFICER

10-02-2026
BRINGS 20+ YEARS OF CLINICAL DEVELOPMENT EXPERIENCE IN AUTOIMMUNE AND INFLAMMATORY DISEASES, INCLUDI...
Více zde

MOONLAKE ANNOUNCES FDA FAST TRACK DESIGNATION FOR SONELOKIMAB PALMOPLANTAR PUSTULOSIS (PPP) AND PROVIDES DETAILS ON UPCOMING INVESTOR DAY

02-02-2026
ZUG, SWITZERLAND, FEBRUARY 2, 2026 – MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ:MLTX) (“MOONLAKE” OR ...
Více zde

MOONLAKE IMMUNOTHERAPEUTICS ANNOUNCES POSITIVE OUTCOME FROM TYPE B MEETING WITH U.S. FDA AND ANNOUNCES INVESTOR DAY

08-01-2026
MOONLAKE REQUESTED A TYPE B MEETING WITH THE U. S. FOOD AND DRUG ADMINISTRATION (FDA) TO OBTAIN REGU...
Více zde

CONTACT LEVI & KORSINSKY BY DECEMBER 15, 2025 DEADLINE TO JOIN CLASS ACTION AGAINST MOONLAKE IMMUNOTHERAPEUTICS(MLTX)

15-12-2025
NEW YORK, DEC. 15, 2025 (GLOBE NEWSWIRE) -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN MOONLAKE IM...
Více zde

MLTX DEADLINE ALERT: HAGENS BERMAN ALERTS MOONLAKE (MLTX) INVESTORS TO TODAY'S LEAD PLAINTIFF DEADLINE IN SECURITIES CLASS ACTION

15-12-2025
SAN FRANCISCO , DEC. 15, 2025 /PRNEWSWIRE/ -- GLOBAL PLAINTIFFS' RIGHTS FIRM HAGENS BERMAN REMINDS I...
Více zde

MOONLAKE IMMUNOTHERAPEUTICS SUED FOR SECURITIES LAW VIOLATIONS - CONTACT THE DJS LAW GROUP TO DISCUSS YOUR RIGHTS – MLTX

15-12-2025
LOS ANGELES--(BUSINESS WIRE)--MOONLAKE IMMUNOTHERAPEUTICS SUED FOR SECURITIES LAW VIOLATIONS - CONTA...
Více zde

MOONLAKE DECEMBER 15TH DEADLINE: BRAGAR EAGEL & SQUIRE, P.C. URGENTLY REMINDS MOONLAKE IMMUNOTHERAPEUTICS INVESTORS TO CONTACT THE FIRM

15-12-2025
BRAGAR EAGEL & SQUIRE, P.C.  LITIGATION PARTNER  BRANDON WALKER  ENCOURAGES INVESTORS WHO SUFFERE...
Více zde

PORTNOY LAW FIRM ANNOUNCES CLASS ACTION ON BEHALF OF MOONLAKE IMMUNOTHERAPEUTICS, INC. INVESTORS

15-12-2025
LOS ANGELES, DEC. 15, 2025 (GLOBE NEWSWIRE) -- THE PORTNOY LAW FIRM ADVISES MOONLAKE IMMUNOTHERAPEUT...
Více zde

FINAL DEADLINE ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF MOONLAKE IMMUNOTHERAPEUTICS

15-12-2025
NEW YORK--(BUSINESS WIRE)---- $MLTX #CLASSACTION--FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIE...
Více zde

SHAREHOLDERS THAT LOST MONEY ON MOONLAKE IMMUNOTHERAPEUTICS(MLTX) URGED TO JOIN CLASS ACTION - CONTACT THE GROSS LAW FIRM TO LEARN MORE

15-12-2025
NEW YORK , DEC. 15, 2025 /PRNEWSWIRE/ -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLD...
Více zde

MLTX INVESTORS HAVE OPPORTUNITY TO LEAD MOONLAKE IMMUNOTHERAPEUTICS SECURITIES FRAUD LAWSUIT WITH THE SCHALL LAW FIRM

15-12-2025
LOS ANGELES--(BUSINESS WIRE)---- $MLTX--MLTX INVESTORS HAVE OPPORTUNITY TO LEAD MOONLAKE IMMUNOTHERA...
Více zde

MOONLAKE IMMUNOTHERAPEUTICS SUED FOR SECURITIES LAW VIOLATIONS - CONTACT THE DJS LAW GROUP TO DISCUSS YOUR RIGHTS - MLTX

15-12-2025
LOS ANGELES , DEC. 15, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP  REMINDS INVESTORS OF A CLASS ACTION ...
Více zde

MLTX INVESTORS HAVE OPPORTUNITY TO LEAD MOONLAKE IMMUNOTHERAPEUTICS SECURITIES FRAUD LAWSUIT WITH THE SCHALL LAW FIRM

15-12-2025
LOS ANGELES , DEC. 15, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LIT...
Více zde

MLTX INVESTOR ALERT: BRONSTEIN, GEWIRTZ & GROSSMAN LLC ANNOUNCES THAT MOONLAKE IMMUNOTHERAPEUTICS INVESTORS WITH SUBSTANTIAL LOSSES HAVE OPPORTUNITY TO LEAD CLASS ACTION LAWSUIT

14-12-2025
NEW YORK, DEC. 14, 2025 (GLOBE NEWSWIRE) -- ATTORNEY ADVERTISING -- BRONSTEIN, GEWIRTZ & GROSSMAN, L...
Více zde

MLTX FINAL DEADLINE ALERT: MOONLAKE (MLTX) CLASS ACTION LAWSUIT - HAGENS BERMAN SCRUTINIZING NANOBODY SUPERIORITY CLAIMS AFTER 90% PLUNGE

14-12-2025
SAN FRANCISCO, CALIFORNIA--(NEWSFILE CORP. - DECEMBER 14, 2025) - GLOBAL PLAINTIFFS' RIGHTS FIRM HAG...
Více zde

MLTX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, ENCOURAGES MOONLAKE IMMUNOTHERAPEUTICS INVESTORS WITH LOSSES IN EXCESS OF $100K TO SECURE COUNSEL BEFORE IMPORTANT DECEMBER 15 DEADLINE IN SECURITIES CLASS ACTION – MLTX

14-12-2025
NEW YORK, DEC. 14, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ...
Více zde

MLTX DEADLINE ALERT: FARUQI & FARUQI, LLP ANNOUNCES THAT MOONLAKE INVESTORS HAVE OPPORTUNITY TO LEAD CLASS ACTION LAWSUIT

14-12-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFF...
Více zde

MLTX SECURITIES LAWSUIT: MOONLAKE IMMUNOTHERAPEUTICS INVESTORS ARE NOTIFIED TO CONTACT BFA LAW BEFORE TOMORROW'S DECEMBER 15 CLASS ACTION DEADLINE

14-12-2025
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 14, 2025) - LEADING SECURITIES LAW FIRM BLEICHMAR FON...
Více zde

MLTX 2-DAY DEADLINE ALERT: MOONLAKE (MLTX) CLASS ACTION LAWSUIT – HAGENS BERMAN SCRUTINIZING NANOBODY SUPERIORITY CLAIMS AFTER 90% PLUNGE; DECEMBER LEAD PLAINTIFF DEADLINE LOOMS

13-12-2025
SAN FRANCISCO, DEC. 13, 2025 (GLOBE NEWSWIRE) -- GLOBAL PLAINTIFFS' RIGHTS FIRM HAGENS BERMAN REMIND...
Více zde

MOONLAKE CLASS ACTION DEADLINE: BRAGAR EAGEL & SQUIRE, P.C. URGENTLY REMINDS MOONLAKE IMMUNOTHERAPEUTICS INVESTORS TO CONTACT THE FIRM BEFORE DECEMBER 15TH

13-12-2025
BRAGAR EAGEL & SQUIRE, P.C.  LITIGATION PARTNER  BRANDON WALKER  ENCOURAGES INVESTORS WHO SUFFERE...
Více zde

MLTX FRAUD UPDATE: IMPORTANT MOONLAKE IMMUNOTHERAPEUTICS SECURITIES FRAUD CLASS ACTION DEADLINE IS APPROACHING FOR INVESTORS – CONTACT BFA LAW BEFORE DECEMBER 15

13-12-2025
NEW YORK, DEC. 13, 2025 (GLOBE NEWSWIRE) -- LEADING SECURITIES LAW FIRM  BLEICHMAR FONTI & AULD LLP...
Více zde

DEADLINE SOON: MOONLAKE IMMUNOTHERAPEUTICS (MLTX) INVESTORS WHO LOST MONEY URGED TO CONTACT THE LAW OFFICES OF FRANK R. CRUZ ABOUT SECURITIES FRAUD LAWSUIT

12-12-2025
LOS ANGELES--(BUSINESS WIRE)--THE LAW OFFICES OF FRANK R. CRUZ REMINDS INVESTORS OF THE UPCOMING DEC...
Více zde

MOONLAKE IMMUNOTHERAPEUTICS SUED FOR SECURITIES LAW VIOLATIONS – INVESTORS SHOULD CONTACT LEVI & KORSINSKY FOR MORE INFORMATION – MLTX

12-12-2025
NEW YORK, DEC. 12, 2025 (GLOBE NEWSWIRE) -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN MOONLAKE IMM...
Více zde

MLTX DEADLINE: MLTX INVESTORS WITH LOSSES IN EXCESS OF $100K HAVE OPPORTUNITY TO LEAD MOONLAKE IMMUNOTHERAPEUTICS SECURITIES FRAUD LAWSUIT

12-12-2025
NEW YORK , DEC. 12, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, RE...
Více zde

MLTX DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, ENCOURAGES MOONLAKE IMMUNOTHERAPEUTICS INVESTORS WITH LOSSES IN EXCESS OF $100K TO SECURE COUNSEL BEFORE IMPORTANT DECEMBER 15 DEADLINE IN SECURITIES CLASS ACTION - MLTX

12-12-2025
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 12, 2025) - WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR R...
Více zde

MLTX INVESTOR DEADLINE ALERT: MOONLAKE (MLTX) CLASS ACTION LAWSUIT - HAGENS BERMAN SCRUTINIZING NANOBODY SUPERIORITY CLAIMS AFTER 90% PLUNGE; DECEMBER LEAD PLAINTIFF DEADLINE LOOMS

12-12-2025
SAN FRANCISCO , DEC. 12, 2025 /PRNEWSWIRE/ -- GLOBAL PLAINTIFFS' RIGHTS FIRM HAGENS BERMAN REMINDS I...
Více zde

MLTX DEADLINE: FARUQI & FARUQI REMINDS MOONLAKE INVESTORS OF THE PENDING CLASS ACTION LAWSUIT WITH A LEAD PLAINTIFF DEADLINE OF DECEMBER 15, 2025 - MLTX

12-12-2025
FARUQI & FARUQI, LLP SECURITIES LITIGATION PARTNER JAMES (JOSH) WILSON ENCOURAGES INVESTORS WHO SUFF...
Více zde

MOONLAKE IMMUNOTHERAPEUTICS CLASS ACTION: LEVI & KORSINSKY REMINDS MOONLAKE INVESTORS OF THE PENDING CLASS ACTION LAWSUIT WITH A LEAD PLAINTIFF DEADLINE OF DECEMBER 15, 2025 - MLTX

12-12-2025
NEW YORK , DEC. 12, 2025 /PRNEWSWIRE/ -- LEVI & KORSINSKY, LLP NOTIFIES INVESTORS IN MOONLAKE IMMUNO...
Více zde

MOONLAKE NOTICE: MOONLAKE IMMUNOTHERAPEUTICS (MLTX) INVESTORS ARE NOTIFIED OF SECURITIES FRAUD CLASS ACTION AND TO CONTACT BFA LAW BY DECEMBER 15

12-12-2025
NEW YORK, NEW YORK--(NEWSFILE CORP. - DECEMBER 12, 2025) - LEADING SECURITIES LAW FIRM BLEICHMAR FON...
Více zde

HOLZER & HOLZER, LLC REMINDS INVESTORS OF UPCOMING LEAD PLAINTIFF DEADLINES IN SHAREHOLDER CLASS ACTION LAWSUITS AGAINST MOONLAKE IMMUNOTHERAPEUTICS (MLTX), DEXCOM, INC. (DXCM), AND SYNOPSYS, INC. (SNPS)

12-12-2025
ATLANTA, DEC. 12, 2025 (GLOBE NEWSWIRE) -- HOLZER & HOLZER, LLC REMINDS INVESTORS OF THE DEADLINE TO...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-08 00:00:008-KStáhnout
2025-11-05 00:00:008-KStáhnout
2025-11-05 00:00:0010-QStáhnout
2025-09-29 01:00:008-KStáhnout
2025-09-29 00:00:008-KStáhnout
2025-08-05 01:00:008-KStáhnout
2025-08-05 01:00:0010-QStáhnout
2025-08-05 00:00:008-KStáhnout
2025-08-05 00:00:0010-QStáhnout
2025-06-06 01:00:008-KStáhnout
2025-06-06 00:00:008-KStáhnout
2025-05-12 01:00:008-KStáhnout
2025-05-12 01:00:0010-QStáhnout
2025-05-12 00:00:008-KStáhnout
2025-05-12 00:00:0010-QStáhnout
2025-04-29 01:00:008-KStáhnout
2025-04-29 00:00:008-KStáhnout
2025-04-03 01:00:008-KStáhnout
2025-04-03 00:00:008-KStáhnout
2025-02-26 00:00:008-KStáhnout
2025-02-26 00:00:0010-KStáhnout
2025-02-25 23:00:008-KStáhnout
2025-02-25 23:00:0010-KStáhnout
2024-12-18 00:00:008-KStáhnout
2024-12-17 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-09-11 01:00:008-KStáhnout
2024-09-11 00:00:008-KStáhnout
2024-08-07 01:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:008-KStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-06-10 01:00:008-KStáhnout
2024-06-10 00:00:008-KStáhnout
2024-06-06 01:00:008-KStáhnout
2024-06-06 00:00:008-KStáhnout
2024-05-07 01:00:008-KStáhnout
2024-05-07 01:00:0010-QStáhnout
2024-05-07 00:00:008-KStáhnout
2024-05-07 00:00:0010-QStáhnout
2024-03-11 00:00:008-KStáhnout
2024-03-10 23:00:008-KStáhnout
2024-02-29 00:00:008-KStáhnout
2024-02-29 00:00:0010-KStáhnout
2024-02-28 23:00:008-KStáhnout
2024-02-28 23:00:0010-KStáhnout
2024-02-26 00:00:008-KStáhnout
2024-02-25 23:00:008-KStáhnout
2023-11-06 00:00:008-KStáhnout
2023-11-05 23:00:008-KStáhnout
2023-10-16 01:00:008-KStáhnout
2023-10-16 00:00:008-KStáhnout
2023-09-11 01:00:008-KStáhnout
2023-09-11 00:00:008-KStáhnout
2023-09-01 01:00:008-KStáhnout
2023-09-01 00:00:008-KStáhnout
2023-08-10 01:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:008-KStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-06-29 01:00:008-KStáhnout
2023-06-29 00:00:008-KStáhnout
2023-06-26 01:00:008-KStáhnout
2023-06-26 00:00:008-KStáhnout
2023-06-07 01:00:008-KStáhnout
2023-06-07 00:00:008-KStáhnout
2023-05-19 01:00:008-KStáhnout
2023-05-19 00:00:008-KStáhnout
2023-05-11 01:00:0010-QStáhnout
2023-05-11 00:00:0010-QStáhnout
2023-04-19 01:00:008-KStáhnout
2023-04-19 00:00:008-KStáhnout
2023-03-20 00:00:008-KStáhnout
2023-03-20 00:00:0010-KStáhnout
2023-03-19 23:00:008-KStáhnout
2023-03-19 23:00:0010-KStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-09 23:00:008-KStáhnout
2022-11-14 00:00:0010-QStáhnout
2022-11-13 23:00:0010-QStáhnout
2022-08-12 01:00:0010-QStáhnout
2022-08-12 00:00:0010-QStáhnout
2022-06-17 01:00:008-KStáhnout
2022-06-17 00:00:008-KStáhnout
2022-06-07 01:00:008-KStáhnout
2022-06-07 00:00:008-KStáhnout
2022-05-16 01:00:0010-QStáhnout
2022-05-16 00:00:0010-QStáhnout
2022-04-11 01:00:008-KStáhnout
2022-04-11 00:00:008-KStáhnout
2022-03-31 01:00:008-KStáhnout
2022-03-31 00:00:008-KStáhnout
2022-03-24 00:00:008-KStáhnout
2022-03-23 23:00:008-KStáhnout
2022-02-25 00:00:008-KStáhnout
2022-02-24 23:00:008-KStáhnout
2022-02-17 00:00:0010-KStáhnout
2022-02-16 23:00:0010-KStáhnout
2021-12-03 00:00:008-KStáhnout
2021-12-02 23:00:008-KStáhnout
2021-11-12 00:00:0010-QStáhnout
2021-11-11 23:00:0010-QStáhnout
2021-10-04 01:00:008-KStáhnout
2021-10-04 00:00:008-KStáhnout
2021-08-16 01:00:0010-QStáhnout
2021-08-16 00:00:0010-QStáhnout
2021-05-21 01:00:0010-QStáhnout
2021-05-21 00:00:0010-QStáhnout
2021-05-03 01:00:008-KStáhnout
2021-05-03 00:00:008-KStáhnout
2021-03-31 01:00:0010-KStáhnout
2021-03-31 00:00:0010-KStáhnout
2020-12-03 00:00:0010-QStáhnout
2020-12-02 23:00:0010-QStáhnout
2020-10-28 00:00:008-KStáhnout
2020-10-27 23:00:008-KStáhnout
2020-10-22 01:00:008-KStáhnout
2020-10-22 00:00:008-KStáhnout
preloader